Kenneth D. Levy

862 total citations
13 papers, 301 citations indexed

About

Kenneth D. Levy is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Kenneth D. Levy has authored 13 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Pharmacology. Recurrent topics in Kenneth D. Levy's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmaceutical studies and practices (6 papers). Kenneth D. Levy is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmaceutical studies and practices (6 papers). Kenneth D. Levy collaborates with scholars based in United States. Kenneth D. Levy's co-authors include Toni I. Pollin, Victoria M. Pratt, Brian S. Decker, Carol R. Horowitz, Marc B. Rosenman, Amanda R. Elsey, Ann Holmes, Andrea H. Ramirez, Kezhen Fei and Aniwaa Owusu Obeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Genetics in Medicine and Frontiers in Genetics.

In The Last Decade

Kenneth D. Levy

13 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth D. Levy United States	7	138	116	107	89	71	13	301
Leland E. Hull United States	9	112 0.8×	104 0.9×	86 0.8×	46 0.5×	38 0.5×	22	284
Yee Ming Lee United States	12	174 1.3×	61 0.5×	119 1.1×	54 0.6×	41 0.6×	22	345
Catherine Chanfreau‐Coffinier United States	8	94 0.7×	44 0.4×	65 0.6×	46 0.5×	59 0.8×	31	256
Dyson T. Wake United States	8	241 1.7×	61 0.5×	165 1.5×	74 0.8×	56 0.8×	13	358
Cathelijne H. van der Wouden Netherlands	8	251 1.8×	142 1.2×	142 1.3×	71 0.8×	54 0.8×	10	493
Eric T. Matey United States	6	97 0.7×	44 0.4×	63 0.6×	40 0.4×	17 0.2×	12	194
Sarah Morris United States	7	82 0.6×	31 0.3×	67 0.6×	27 0.3×	29 0.4×	18	229
JS Schildcrout United States	2	217 1.6×	65 0.6×	141 1.3×	17 0.2×	47 0.7×	2	297
Emily J. Cicali United States	9	170 1.2×	36 0.3×	99 0.9×	33 0.4×	33 0.5×	28	261
Kristin Wiisanen United States	9	162 1.2×	33 0.3×	88 0.8×	34 0.4×	25 0.4×	20	213

Countries citing papers authored by Kenneth D. Levy

Since Specialization

Citations

This map shows the geographic impact of Kenneth D. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth D. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth D. Levy more than expected).

Fields of papers citing papers by Kenneth D. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth D. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth D. Levy. The network helps show where Kenneth D. Levy may publish in the future.

Co-authorship network of co-authors of Kenneth D. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth D. Levy. A scholar is included among the top collaborators of Kenneth D. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth D. Levy. Kenneth D. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sperber, Nina, Megan C. Roberts, Paul Dexter, et al.. (2021). Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network. Journal of Personalized Medicine. 11(7). 647–647. 18 indexed citations

Levy, Kenneth D., et al.. (2020). Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial. Frontiers in Genetics. 11. 571–571. 6 indexed citations

Levy, Kenneth D., R. Ryanne Wu, Daisuke Goto, et al.. (2020). Translating pharmacogenetics from research to routine clinical practice – a survey of the IGNITE Network. SHILAP Revista de lepidopterología. 5(1). 3 indexed citations

Orlando, Lori A., Corrine I. Voils, Carol R. Horowitz, et al.. (2019). IGNITE network: Response of patients to genomic medicine interventions. Molecular Genetics & Genomic Medicine. 7(5). e636–e636. 5 indexed citations

Zang, Yong, Zeruesenay Desta, Marc B. Rosenman, et al.. (2019). Drug–Gene and Drug–Drug Interactions Associated with Tramadol and Codeine Therapy in the INGENIOUS Trial. Pharmacogenomics. 20(6). 397–408. 13 indexed citations

Levy, Kenneth D., Kathryn Blake, James P. Franciosi, et al.. (2018). Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network. Genetics in Medicine. 21(3). 743–747. 36 indexed citations

Obeng, Aniwaa Owusu, Kezhen Fei, Kenneth D. Levy, et al.. (2018). Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey. Journal of Personalized Medicine. 8(3). 24–24. 90 indexed citations

Orlando, Lori A., Nina Sperber, Corrine I. Voils, et al.. (2017). Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network’s Common Measures Working Group. Genetics in Medicine. 20(6). 655–663. 49 indexed citations

Carpenter, Janet S., Marc B. Rosenman, Mitchell R. Knisely, et al.. (2016). Pharmacogenomically actionable medications in a safety net health care system. PMC. 2 indexed citations

10.

Rosenman, Marc B., Brian S. Decker, Kenneth D. Levy, et al.. (2016). Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice. Value in Health. 20(1). 54–59. 49 indexed citations

11.

Carpenter, Janet S., Marc B. Rosenman, Mitchell R. Knisely, et al.. (2016). Pharmacogenomically actionable medications in a safety net health care system. SAGE Open Medicine. 4. 2102696333–2102696333. 20 indexed citations

12.

Levy, Kenneth D., Victoria M. Pratt, Todd C. Skaar, Gail H. Vance, & David A. Flockhart. (2015). FDA's draft guidance on laboratory‐developed tests increases clinical and economic risk to adoption of pharmacogenetic testing. The Journal of Clinical Pharmacology. 55(7). 725–727. 6 indexed citations

13.

Pratt, Victoria M., Daniel L. Koller, Todd C. Skaar, et al.. (2014). Report of New Haplotype for ABCC2 Gene. Journal of Molecular Diagnostics. 17(2). 201–205. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact